Quilseconazole manufacturers
- Quilseconazole
-
- $2360.00
-
2026-05-11
- CAS:1340593-70-5
- Purity:
- Supply Ability: 10g
|
| | Quilseconazole Basic information |
| Product Name: | Quilseconazole | | Synonyms: | Quilseconazole;2-Pyridineethanol, α-(2,4-difluorophenyl)-β,β-difluoro-α-(1H-tetrazol-1-ylmethyl)-5-[4-(trifluoromethoxy)phenyl]-, (αR)-;Quilseconazole,
VT-1129;VT-1129 | | CAS: | 1340593-70-5 | | MF: | C22H14F7N5O2 | | MW: | 513.38 | | EINECS: | | | Product Categories: | | | Mol File: | 1340593-70-5.mol |  |
| | Quilseconazole Chemical Properties |
| Boiling point | 583.9±60.0 °C(Predicted) | | density | 1.50±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 10.47±0.29(Predicted) | | form | Solid | | color | White to off-white |
| | Quilseconazole Usage And Synthesis |
| Uses | Quilseconazole (VT-1129) is a potent, orally active fungal Cyp51 (lanosterol 14-α-demethylase) inhibitor, binds tightly to cryptococcal CYP51, but weakly inhibits humans CYP450 enzymes[1]. | | IC 50 | CYP51 | | References | [1] Lockhart SR, et al. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2528-31. DOI:10.1128/AAC.02770-15 |
| | Quilseconazole Preparation Products And Raw materials |
|